رجوع
0
نطاق اليوم
KWD 30.30
KWD 30.30
نطاق 52 أسبوعًا
KWD 30.30
KWD 30.30
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 30.30
/
KWD 30.30
الإغلاق السابق
KWD 30.30
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 8.4 | 3.7 |
| Net Margin % | 1.4 | 3.8 |
| Rev Growth 5Y % | 3.1 | 10.0 |
| D/E | 0.0 | 0.2 |
النقاط الرئيسية
Revenue grew 3.05% annually over 5 years — modest growth
Earnings grew 18.89% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -83.73B
P/E of 0.05 — trading at a low valuation
PEG of 0.37 suggests growth is underpriced
النمو
Revenue Growth (5Y)
3.05%
Revenue (1Y)0.56%
Earnings (1Y)18.89%
FCF Growth (3Y)N/A
الجودة
Return on Equity
8.38%
ROIC6.84%
Net Margin1.44%
Op. Margin1.55%
الأمان
Debt / Equity
0.00
Current Ratio1.24
Interest Coverage905.49
التقييم
P/E Ratio
0.05
P/B Ratio0.00
EV/EBITDA-2.72
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.56% | Revenue Growth (3Y) | 1.82% |
| Earnings Growth (1Y) | 18.89% | Earnings Growth (3Y) | 30.21% |
| Revenue Growth (5Y) | 3.05% | Earnings Growth (5Y) | 44.58% |
| Profitability | |||
| Revenue (TTM) | 2.40T | Net Income (TTM) | 34.50B |
| ROE | 8.38% | ROA | 3.10% |
| Gross Margin | 8.01% | Operating Margin | 1.55% |
| Net Margin | 1.44% | Free Cash Flow (TTM) | -83.73B |
| ROIC | 6.84% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 1.24 |
| Interest Coverage | 905.49 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 0.05 | P/B Ratio | 0.00 |
| P/S Ratio | 0.00 | PEG Ratio | 0.37 |
| EV/EBITDA | -2.72 | Dividend Yield | 0.02% |
| Market Cap | 1.72B | Enterprise Value | -100.94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.40T | 2.39T | 2.31T | 2.23T | 2.13T |
| Net Income | 34.50B | 29.02B | 20.35B | 14.39B | 7.90B |
| EPS (Diluted) | 454.58 | 357.87 | 236.46 | 163.18 | 88.51 |
| Gross Profit | 192.23B | 185.25B | 179.70B | 160.99B | 157.84B |
| Operating Income | 37.13B | 34.88B | 32.61B | 20.12B | 9.16B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.11T | 1.23T | 1.15T | 1.14T | 1.11T |
| Total Liabilities | 706.41B | 812.26B | 734.57B | 723.66B | 696.51B |
| Shareholders' Equity | 407.29B | 416.31B | 411.21B | 417.69B | 417.05B |
| Total Debt | 0.0 | 1.80B | 1.80B | 2.12B | 2.28B |
| Cash & Equivalents | 102.66B | 181.83B | 109.03B | 141.38B | 151.12B |
| Current Assets | 844.10B | 948.29B | 878.17B | 882.94B | 859.73B |
| Current Liabilities | 679.11B | 784.42B | 711.27B | 697.88B | 670.07B |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#705 of 708
النشاط الأخير
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026